Published in Proc Natl Acad Sci U S A on April 20, 2009
Target profiling of small molecules by chemical proteomics. Nat Chem Biol (2009) 3.20
Structure and dynamics of molecular networks: a novel paradigm of drug discovery: a comprehensive review. Pharmacol Ther (2013) 2.64
Affinity-based proteomics reveal cancer-specific networks coordinated by Hsp90. Nat Chem Biol (2011) 2.42
Functional proteomics to dissect tyrosine kinase signalling pathways in cancer. Nat Rev Cancer (2010) 1.97
BCR-ABL uncouples canonical JAK2-STAT5 signaling in chronic myeloid leukemia. Nat Chem Biol (2012) 1.77
A potent and highly specific FN3 monobody inhibitor of the Abl SH2 domain. Nat Struct Mol Biol (2010) 1.47
Interlaboratory reproducibility of large-scale human protein-complex analysis by standardized AP-MS. Nat Methods (2013) 1.30
Navigating cancer network attractors for tumor-specific therapy. Nat Biotechnol (2012) 1.18
Initial characterization of the human central proteome. BMC Syst Biol (2011) 1.18
Profiling of protein interaction networks of protein complexes using affinity purification and quantitative mass spectrometry. Mol Cell Proteomics (2010) 1.13
Biochemical characterization of highly purified leucine-rich repeat kinases 1 and 2 demonstrates formation of homodimers. PLoS One (2012) 1.09
Downregulation of miR-31, miR-155, and miR-564 in chronic myeloid leukemia cells. PLoS One (2012) 1.00
The proximal signaling network of the BCR-ABL1 oncogene shows a modular organization. Oncogene (2010) 0.98
Using iTRAQ combined with tandem affinity purification to enhance low-abundance proteins associated with somatically mutated EGFR core complexes in lung cancer. J Proteome Res (2010) 0.98
Mapping protein interactions by combining antibody affinity maturation and mass spectrometry. Anal Biochem (2011) 0.96
Lesson from the stoichiometry determination of the cohesin complex: a short protease mediated elution increases the recovery from cross-linked antibody-conjugated beads. J Proteome Res (2010) 0.96
A method to resolve the composition of heterogeneous affinity-purified protein complexes assembled around a common protein by chemical cross-linking, gel electrophoresis and mass spectrometry. Nat Protoc (2012) 0.95
Mathematical modeling as a tool for planning anticancer therapy. Eur J Pharmacol (2009) 0.92
Structure, regulation, signaling, and targeting of abl kinases in cancer. Genes Cancer (2012) 0.90
Dissection of the BCR-ABL signaling network using highly specific monobody inhibitors to the SHP2 SH2 domains. Proc Natl Acad Sci U S A (2013) 0.90
Gene Expression Differences between Enriched Normal and Chronic Myelogenous Leukemia Quiescent Stem/Progenitor Cells and Correlations with Biological Abnormalities. J Oncol (2011) 0.89
Alterations of Gab2 signalling complexes in imatinib and dasatinib treated chronic myeloid leukaemia cells. Cell Commun Signal (2013) 0.86
A computational approach to analyze the mechanism of action of the kinase inhibitor bafetinib. PLoS Comput Biol (2010) 0.85
NUP214-ABL1-mediated cell proliferation in T-cell acute lymphoblastic leukemia is dependent on the LCK kinase and various interacting proteins. Haematologica (2013) 0.85
BCR-ABL1 promotes leukemia by converting p27 into a cytoplasmic oncoprotein. Blood (2014) 0.84
A target-disease network model of second-generation BCR-ABL inhibitor action in Ph+ ALL. PLoS One (2013) 0.79
The proteomics big challenge for biomarkers and new drug-targets discovery. Int J Mol Sci (2012) 0.79
Low expression of Abelson interactor-1 is linked to acquired drug resistance in Bcr-Abl-induced leukemia. Leukemia (2014) 0.79
Naturally Occurring Isothiocyanates Exert Anticancer Effects by Inhibiting Deubiquitinating Enzymes. Cancer Res (2015) 0.78
Binding Mechanism of the N-Terminal SH3 Domain of CrkII and Proline-Rich Motifs in cAbl. Biophys J (2016) 0.76
DEFOG: discrete enrichment of functionally organized genes. Integr Biol (Camb) (2012) 0.76
Embryonal Fyn-associated substrate (EFS) and CASS4: The lesser-known CAS protein family members. Gene (2015) 0.76
Combination of a proteomics approach and reengineering of meso scale network models for prediction of mode-of-action for tyrosine kinase inhibitors. PLoS One (2013) 0.76
IQGAP1 is a phosphoinositide effector and kinase scaffold. Adv Biol Regul (2015) 0.76
Systems pharmacology and enhanced pharmacodynamic models for understanding antibody-based drug action and toxicity. MAbs (2016) 0.75
Kinetic Insights into the Binding between the nSH3 Domain of CrkII and Proline-Rich Motifs in cAbl. Biophys J (2016) 0.75
Combined Population Dynamics and Entropy Modelling Supports Patient Stratification in Chronic Myeloid Leukemia. Sci Rep (2016) 0.75
Rationalising the role of Keratin 9 as a biomarker for Alzheimer's disease. Sci Rep (2016) 0.75
New Abelson interactor-1 (Abi-1)-driven mechanism of acquired drug resistance. Leuk Suppl (2014) 0.75
ChiPPI: a novel method for mapping chimeric protein-protein interactions uncovers selection principles of protein fusion events in cancer. Nucleic Acids Res (2017) 0.75
A Split-Abl Kinase for Direct Activation in Cells. Cell Chem Biol (2017) 0.75
Differential signaling networks of Bcr-Abl p210 and p190 kinases in leukemia cells defined by functional proteomics. Leukemia (2017) 0.75
Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A (2001) 132.88
Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal Chem (1996) 45.70
Proteome survey reveals modularity of the yeast cell machinery. Nature (2006) 20.77
Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol Cell Proteomics (2004) 19.05
The International Protein Index: an integrated database for proteomics experiments. Proteomics (2004) 14.67
Stop and go extraction tips for matrix-assisted laser desorption/ionization, nanoelectrospray, and LC/MS sample pretreatment in proteomics. Anal Chem (2003) 13.58
Drug-target network. Nat Biotechnol (2007) 11.15
Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome. Science (1990) 10.59
Drug target identification using side-effect similarity. Science (2008) 9.24
Pharmacogenomics--drug disposition, drug targets, and side effects. N Engl J Med (2003) 7.23
A physical and functional map of the human TNF-alpha/NF-kappa B signal transduction pathway. Nat Cell Biol (2004) 7.23
A combined experimental and computational strategy to define protein interaction networks for peptide recognition modules. Science (2001) 7.08
The development of imatinib as a therapeutic agent for chronic myeloid leukemia. Blood (2004) 6.92
Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors. Nat Biotechnol (2007) 6.56
Analysis of protein complexes using mass spectrometry. Nat Rev Mol Cell Biol (2007) 4.70
Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia. Nat Rev Cancer (2005) 4.30
Bcr-Abl kinase domain mutations, drug resistance, and the road to a cure for chronic myeloid leukemia. Blood (2007) 4.15
Cbl: many adaptations to regulate protein tyrosine kinases. Nat Rev Mol Cell Biol (2001) 4.11
Class I PI3K in oncogenic cellular transformation. Oncogene (2008) 3.90
Chemical proteomic profiles of the BCR-ABL inhibitors imatinib, nilotinib, and dasatinib reveal novel kinase and nonkinase targets. Blood (2007) 3.59
An efficient tandem affinity purification procedure for interaction proteomics in mammalian cells. Nat Methods (2006) 3.38
The origin of protein interactions and allostery in colocalization. Nature (2007) 3.34
BCR-ABL tyrosine kinase inhibitors for chronic myelogenous leukemia. N Engl J Med (2007) 3.16
Dasatinib, a small-molecule protein tyrosine kinase inhibitor, inhibits T-cell activation and proliferation. Blood (2007) 3.13
Regulation of the c-Abl and Bcr-Abl tyrosine kinases. Nat Rev Mol Cell Biol (2004) 3.10
The BCR-ABL story: bench to bedside and back. Annu Rev Immunol (2004) 3.00
Hit and lead generation: beyond high-throughput screening. Nat Rev Drug Discov (2003) 2.81
The Btk tyrosine kinase is a major target of the Bcr-Abl inhibitor dasatinib. Proc Natl Acad Sci U S A (2007) 2.51
The Abl family kinases: mechanisms of regulation and signaling. Adv Cancer Res (2002) 2.49
Rediscovering the sweet spot in drug discovery. Drug Discov Today (2003) 2.45
Critical role for Gab2 in transformation by BCR/ABL. Cancer Cell (2002) 2.42
Flying under the radar: the new wave of BCR-ABL inhibitors. Nat Rev Drug Discov (2007) 2.40
Dynamic control of signaling by modular adaptor proteins. Curr Opin Cell Biol (2007) 2.10
Profiling core proteomes of human cell lines by one-dimensional PAGE and liquid chromatography-tandem mass spectrometry. Mol Cell Proteomics (2003) 1.82
An intramolecular SH3-domain interaction regulates c-Abl activity. Nat Genet (1998) 1.71
Profiling of tyrosine phosphorylation pathways in human cells using mass spectrometry. Proc Natl Acad Sci U S A (2003) 1.68
Target spectrum of the BCR-ABL inhibitors imatinib, nilotinib and dasatinib. Leuk Lymphoma (2008) 1.63
A phosphatase activity of Sts-1 contributes to the suppression of TCR signaling. Mol Cell (2007) 1.43
5' phospholipid phosphatase SHIP-2 causes protein kinase B inactivation and cell cycle arrest in glioblastoma cells. Mol Cell Biol (2000) 1.31
Molecular mechanisms of transformation by the BCR-ABL oncogene. Semin Hematol (2003) 1.26
Monoclonal antibodies specific for v-abl- and c-abl-encoded molecules. J Virol (1986) 1.21
Structural basis for the cytoskeletal association of Bcr-Abl/c-Abl. Mol Cell (2005) 1.21
Oncogenic signaling: new insights and controversies from chronic myeloid leukemia. J Exp Med (2007) 1.13
Identification, cDNA cloning, and targeted deletion of p70, a novel, ubiquitously expressed SH3 domain-containing protein. Mol Cell Biol (2002) 1.10
SHP-2 phosphatase is required for hematopoietic cell transformation by Bcr-Abl. Blood (2006) 0.91
The chemokine interleukin-8 and the surface activation protein CD69 are markers for Bcr-Abl activity in chronic myeloid leukemia. Mol Oncol (2008) 0.89
Phosphotyrosine mapping in Bcr/Abl oncoprotein using phosphotyrosine-specific immonium ion scanning. Mol Cell Proteomics (2003) 0.85
Functional organization of the yeast proteome by systematic analysis of protein complexes. Nature (2002) 45.19
Proteome survey reveals modularity of the yeast cell machinery. Nature (2006) 20.77
Partitioning and plasticity of repressive histone methylation states in mammalian chromatin. Mol Cell (2003) 11.33
Somatic mutations of calreticulin in myeloproliferative neoplasms. N Engl J Med (2013) 9.65
The minimum information required for reporting a molecular interaction experiment (MIMIx). Nat Biotechnol (2007) 8.24
An orthogonal proteomic-genomic screen identifies AIM2 as a cytoplasmic DNA sensor for the inflammasome. Nat Immunol (2009) 7.93
A physical and functional map of the human TNF-alpha/NF-kappa B signal transduction pathway. Nat Cell Biol (2004) 7.23
ELM server: A new resource for investigating short functional sites in modular eukaryotic proteins. Nucleic Acids Res (2003) 6.86
BAC TransgeneOmics: a high-throughput method for exploration of protein function in mammals. Nat Methods (2008) 6.51
Reversal of H3K9me2 by a small-molecule inhibitor for the G9a histone methyltransferase. Mol Cell (2007) 5.49
Structural basis for the autoinhibition of c-Abl tyrosine kinase. Cell (2003) 5.44
Peroxisomes are signaling platforms for antiviral innate immunity. Cell (2010) 5.24
Systematic analysis of human protein complexes identifies chromosome segregation proteins. Science (2010) 4.69
Asymmetric segregation of the tumor suppressor brat regulates self-renewal in Drosophila neural stem cells. Cell (2006) 4.52
The CRAPome: a contaminant repository for affinity purification-mass spectrometry data. Nat Methods (2013) 4.34
Human Proteinpedia enables sharing of human protein data. Nat Biotechnol (2008) 4.21
IFIT1 is an antiviral protein that recognizes 5'-triphosphate RNA. Nat Immunol (2011) 4.18
Recruitment of PRC1 function at the initiation of X inactivation independent of PRC2 and silencing. EMBO J (2006) 4.16
Wapl controls the dynamic association of cohesin with chromatin. Cell (2006) 3.83
Protein phosphatase 2A protects centromeric sister chromatid cohesion during meiosis I. Nature (2006) 3.81
Dissociation of cohesin from chromosome arms and loss of arm cohesion during early mitosis depends on phosphorylation of SA2. PLoS Biol (2005) 3.72
The Par complex directs asymmetric cell division by phosphorylating the cytoskeletal protein Lgl. Nature (2003) 3.71
Chemical proteomic profiles of the BCR-ABL inhibitors imatinib, nilotinib, and dasatinib reveal novel kinase and nonkinase targets. Blood (2007) 3.59
The conserved Nup107-160 complex is critical for nuclear pore complex assembly. Cell (2003) 3.58
Mitotic regulation of the human anaphase-promoting complex by phosphorylation. EMBO J (2003) 3.54
A Polycomb group protein complex with sequence-specific DNA-binding and selective methyl-lysine-binding activities. Genes Dev (2006) 3.49
A myristoyl/phosphotyrosine switch regulates c-Abl. Cell (2003) 3.48
Reverse genetics in the mosquito Anopheles gambiae: targeted disruption of the Defensin gene. EMBO Rep (2002) 3.43
An efficient tandem affinity purification procedure for interaction proteomics in mammalian cells. Nat Methods (2006) 3.38
Building sister chromatid cohesion: smc3 acetylation counteracts an antiestablishment activity. Mol Cell (2009) 3.33
Jmjd2b antagonizes H3K9 trimethylation at pericentric heterochromatin in mammalian cells. Genes Dev (2006) 3.24
Target profiling of small molecules by chemical proteomics. Nat Chem Biol (2009) 3.20
RNase P without RNA: identification and functional reconstitution of the human mitochondrial tRNA processing enzyme. Cell (2008) 3.15
Regulation of the c-Abl and Bcr-Abl tyrosine kinases. Nat Rev Mol Cell Biol (2004) 3.10
Universal and confident phosphorylation site localization using phosphoRS. J Proteome Res (2011) 2.93
Live-cell imaging RNAi screen identifies PP2A-B55alpha and importin-beta1 as key mitotic exit regulators in human cells. Nat Cell Biol (2010) 2.91
Structure-based assembly of protein complexes in yeast. Science (2004) 2.89
HURP is part of a Ran-dependent complex involved in spindle formation. Curr Biol (2006) 2.74
Genome-wide analysis of mRNAs regulated by the THO complex in Drosophila melanogaster. Nat Struct Mol Biol (2004) 2.70
Monopolar attachment of sister kinetochores at meiosis I requires casein kinase 1. Cell (2006) 2.70
ATP hydrolysis is required for cohesin's association with chromosomes. Curr Biol (2003) 2.69
Structure of the anaphase-promoting complex/cyclosome interacting with a mitotic checkpoint complex. Science (2009) 2.69
Complement factor H binds malondialdehyde epitopes and protects from oxidative stress. Nature (2011) 2.64
Aurora A phosphorylation of TACC3/maskin is required for centrosome-dependent microtubule assembly in mitosis. J Cell Biol (2005) 2.57
Mei-P26 regulates microRNAs and cell growth in the Drosophila ovarian stem cell lineage. Nature (2008) 2.54
A chemical and phosphoproteomic characterization of dasatinib action in lung cancer. Nat Chem Biol (2010) 2.53
The Btk tyrosine kinase is a major target of the Bcr-Abl inhibitor dasatinib. Proc Natl Acad Sci U S A (2007) 2.51
An in vivo RNAi assay identifies major genetic and cellular requirements for primary piRNA biogenesis in Drosophila. EMBO J (2010) 2.51
Pcl-PRC2 is needed to generate high levels of H3-K27 trimethylation at Polycomb target genes. EMBO J (2007) 2.49
Laser microsurgery provides evidence for merotelic kinetochore attachments in fission yeast cells lacking Pcs1 or Clr4. Cell Cycle (2010) 2.48
Structural coupling of SH2-kinase domains links Fes and Abl substrate recognition and kinase activation. Cell (2008) 2.46
Rediscovering the sweet spot in drug discovery. Drug Discov Today (2003) 2.45
NSs protein of rift valley fever virus induces the specific degradation of the double-stranded RNA-dependent protein kinase. J Virol (2009) 2.39
Organization of the SH3-SH2 unit in active and inactive forms of the c-Abl tyrosine kinase. Mol Cell (2006) 2.28
RhoB and actin polymerization coordinate Src activation with endosome-mediated delivery to the membrane. Dev Cell (2004) 2.13
Sororin mediates sister chromatid cohesion by antagonizing Wapl. Cell (2010) 2.12
Targeting the SH2-kinase interface in Bcr-Abl inhibits leukemogenesis. Cell (2011) 2.11
Generation and characterization of methyl-lysine histone antibodies. Methods Enzymol (2004) 2.09
Mass spectrometry-based functional proteomics: from molecular machines to protein networks. Nat Methods (2007) 2.06
Eco1 is a novel acetyltransferase that can acetylate proteins involved in cohesion. Curr Biol (2002) 2.04
HSPC117 is the essential subunit of a human tRNA splicing ligase complex. Science (2011) 2.03
c-Src-mediated phosphorylation of hnRNP K drives translational activation of specifically silenced mRNAs. Mol Cell Biol (2002) 1.98
Autoinhibition of c-Abl. Cell (2002) 1.93
Viral immune modulators perturb the human molecular network by common and unique strategies. Nature (2012) 1.86
Sororin is required for stable binding of cohesin to chromatin and for sister chromatid cohesion in interphase. Curr Biol (2007) 1.79
Systems medicine and integrated care to combat chronic noncommunicable diseases. Genome Med (2011) 1.78
BCR-ABL uncouples canonical JAK2-STAT5 signaling in chronic myeloid leukemia. Nat Chem Biol (2012) 1.77
The DEAD-box helicase DDX3X is a critical component of the TANK-binding kinase 1-dependent innate immune response. EMBO J (2008) 1.76